Associated Papers
Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients.
Ohno M et al.
European Journal of Clinical Pharmacology, 2009
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
Scott SA et al.
Pharmacogenomics, 2009
[Genetic testing].
Azuma J et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine, 2007
Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII.
Yildirim E et al.
Hippokratia, 0
Select a paper to view details